BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 25860483)

  • 1. Slug-dependent upregulation of L1CAM is responsible for the increased invasion potential of pancreatic cancer cells following long-term 5-FU treatment.
    Lund K; Dembinski JL; Solberg N; Urbanucci A; Mills IG; Krauss S
    PLoS One; 2015; 10(4):e0123684. PubMed ID: 25860483
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Binding of the transcription factor Slug to the L1CAM promoter is essential for transforming growth factor-β1 (TGF-β)-induced L1CAM expression in human pancreatic ductal adenocarcinoma cells.
    Geismann C; Arlt A; Bauer I; Pfeifer M; Schirmer U; Altevogt P; Müerköster SS; Schäfer H
    Int J Oncol; 2011 Jan; 38(1):257-66. PubMed ID: 21109948
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Up-regulation of L1CAM in pancreatic duct cells is transforming growth factor beta1- and slug-dependent: role in malignant transformation of pancreatic cancer.
    Geismann C; Morscheck M; Koch D; Bergmann F; Ungefroren H; Arlt A; Tsao MS; Bachem MG; Altevogt P; Sipos B; Fölsch UR; Schäfer H; Müerköster SS
    Cancer Res; 2009 May; 69(10):4517-26. PubMed ID: 19435915
    [TBL] [Abstract][Full Text] [Related]  

  • 4. L1CAM expression in endometrial carcinomas is regulated by usage of two different promoter regions.
    Pfeifer M; Schirmer U; Geismann C; Schäfer H; Sebens S; Altevogt P
    BMC Mol Biol; 2010 Aug; 11():64. PubMed ID: 20799950
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drug-induced expression of the cellular adhesion molecule L1CAM confers anti-apoptotic protection and chemoresistance in pancreatic ductal adenocarcinoma cells.
    Sebens Müerköster S; Werbing V; Sipos B; Debus MA; Witt M; Grossmann M; Leisner D; Kötteritzsch J; Kappes H; Klöppel G; Altevogt P; Fölsch UR; Schäfer H
    Oncogene; 2007 Apr; 26(19):2759-68. PubMed ID: 17086212
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Up-regulation of L1CAM is linked to loss of hormone receptors and E-cadherin in aggressive subtypes of endometrial carcinomas.
    Huszar M; Pfeifer M; Schirmer U; Kiefel H; Konecny GE; Ben-Arie A; Edler L; Münch M; Müller-Holzner E; Jerabek-Klestil S; Abdel-Azim S; Marth C; Zeimet AG; Altevogt P; Fogel M
    J Pathol; 2010 Apr; 220(5):551-61. PubMed ID: 20077528
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TGF-β1-dependent L1CAM expression has an essential role in macrophage-induced apoptosis resistance and cell migration of human intestinal epithelial cells.
    Schäfer H; Struck B; Feldmann EM; Bergmann F; Grage-Griebenow E; Geismann C; Ehlers S; Altevogt P; Sebens S
    Oncogene; 2013 Jan; 32(2):180-9. PubMed ID: 22349829
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chemoresistance to 5-fluorouracil induces epithelial-mesenchymal transition via up-regulation of Snail in MCF7 human breast cancer cells.
    Zhang W; Feng M; Zheng G; Chen Y; Wang X; Pen B; Yin J; Yu Y; He Z
    Biochem Biophys Res Commun; 2012 Jan; 417(2):679-85. PubMed ID: 22166209
    [TBL] [Abstract][Full Text] [Related]  

  • 9. miR-193a-3p inhibition of the Slug activator PAK4 suppresses non-small cell lung cancer aggressiveness via the p53/Slug/L1CAM pathway.
    Liu X; Min S; Wu N; Liu H; Wang T; Li W; Shen Y; Zhao C; Wang H; Qian Z; Xu H; Chen Y; Wang X
    Cancer Lett; 2019 Apr; 447():56-65. PubMed ID: 30685413
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Slug enhances invasion ability of pancreatic cancer cells through upregulation of matrix metalloproteinase-9 and actin cytoskeleton remodeling.
    Zhang K; Chen D; Jiao X; Zhang S; Liu X; Cao J; Wu L; Wang D
    Lab Invest; 2011 Mar; 91(3):426-38. PubMed ID: 21283078
    [TBL] [Abstract][Full Text] [Related]  

  • 11. L1CAM-integrin interaction induces constitutive NF-kappaB activation in pancreatic adenocarcinoma cells by enhancing IL-1beta expression.
    Kiefel H; Bondong S; Erbe-Hoffmann N; Hazin J; Riedle S; Wolf J; Pfeifer M; Arlt A; Schäfer H; Müerköster SS; Altevogt P
    Oncogene; 2010 Aug; 29(34):4766-78. PubMed ID: 20543863
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of BCL9L in transforming growth factor-β (TGF-β)-induced epithelial-to-mesenchymal-transition (EMT) and metastasis of pancreatic cancer.
    Sannino G; Armbruster N; Bodenhöfer M; Haerle U; Behrens D; Buchholz M; Rothbauer U; Sipos B; Schmees C
    Oncotarget; 2016 Nov; 7(45):73725-73738. PubMed ID: 27713160
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human papillomavirus oncoproteins differentially modulate epithelial-mesenchymal transition in 5-FU-resistant cervical cancer cells.
    Vishnoi K; Mahata S; Tyagi A; Pandey A; Verma G; Jadli M; Singh T; Singh SM; Bharti AC
    Tumour Biol; 2016 Oct; 37(10):13137-13154. PubMed ID: 27449048
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drug efflux transporter multidrug resistance-associated protein 5 affects sensitivity of pancreatic cancer cell lines to the nucleoside anticancer drug 5-fluorouracil.
    Nambaru PK; Hübner T; Köck K; Mews S; Grube M; Payen L; Guitton J; Sendler M; Jedlitschky G; Rimmbach C; Rosskopf D; Kowalczyk DW; Kroemer HK; Weiss FU; Mayerle J; Lerch MM; Ritter CA
    Drug Metab Dispos; 2011 Jan; 39(1):132-9. PubMed ID: 20930123
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NRF2 Knockdown Resensitizes 5-Fluorouracil-Resistant Pancreatic Cancer Cells by Suppressing HO-1 and ABCG2 Expression.
    Kim EJ; Kim YJ; Lee HI; Jeong SH; Nam HJ; Cho JH
    Int J Mol Sci; 2020 Jun; 21(13):. PubMed ID: 32629871
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of TGF-β signalling in combination with nal-IRI plus 5-Fluorouracil/Leucovorin suppresses invasion and prolongs survival in pancreatic tumour mouse models.
    Hong E; Park S; Ooshima A; Hong CP; Park J; Heo JS; Lee S; An H; Kang JM; Park SH; Park JO; Kim SJ
    Sci Rep; 2020 Feb; 10(1):2935. PubMed ID: 32076068
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Slug contributes to cadherin switch and malignant progression in muscle-invasive bladder cancer development.
    Wu K; Zeng J; Zhou J; Fan J; Chen Y; Wang Z; Zhang T; Wang X; He D
    Urol Oncol; 2013 Nov; 31(8):1751-60. PubMed ID: 22421353
    [TBL] [Abstract][Full Text] [Related]  

  • 18. EMT-associated up-regulation of L1CAM provides insights into L1CAM-mediated integrin signalling and NF-κB activation.
    Kiefel H; Bondong S; Pfeifer M; Schirmer U; Erbe-Hoffmann N; Schäfer H; Sebens S; Altevogt P
    Carcinogenesis; 2012 Oct; 33(10):1919-29. PubMed ID: 22764136
    [TBL] [Abstract][Full Text] [Related]  

  • 19. L1CAM protein expression is associated with poor prognosis in non-small cell lung cancer.
    Tischler V; Pfeifer M; Hausladen S; Schirmer U; Bonde AK; Kristiansen G; Sos ML; Weder W; Moch H; Altevogt P; Soltermann A
    Mol Cancer; 2011 Oct; 10():127. PubMed ID: 21985405
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification and Clinical Significance of Pancreatic Cancer Stem Cells and Their Chemotherapeutic Drug Resistance.
    Kuo YC; Kou HW; Hsu CP; Lo CH; Hwang TL
    Int J Mol Sci; 2023 Apr; 24(8):. PubMed ID: 37108495
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.